Literature DB >> 2470675

Inactivation of human gamma interferon by Pseudomonas aeruginosa proteases: elastase augments the effects of alkaline protease despite the presence of alpha 2-macroglobulin.

R T Horvat1, M Clabaugh, C Duval-Jobe, M J Parmely.   

Abstract

Pseudomonas aeruginosa alkaline protease (AP) has recently been shown to produce limited proteolysis of human gamma interferon (IFN-gamma) and thereby destroy the antiviral and macrophage-activating activities of the lymphokine. In the present study we describe some of the characteristics of Pseudomonas elastase (E) with regard to inactivation of human IFN-gamma. The inhibitory effect of E on IFN-gamma bioactivity differed from that of AP in that the direct effects of E were reduced in the presence of human serum. That this property of human serum was in large part attributable to the protease inhibitor alpha 2-macroglobulin (alpha 2-M) was suggested by the following observations: (i) methylamine treatment of serum reduced its effect on E, (ii) E interacted directly with alpha 2-M to induce a characteristic conformational change in the protease inhibitor, and (iii) preformed E-alpha 2-M complexes lacked IFN-gamma-degrading activity. Despite these findings, anti-E antiserum partially neutralized the effect that a Pseudomonas filtrate showed on IFN-gamma, suggesting that E contributes to the activity of bacterial filtrates. Treatment of IFN-gamma with E in the presence of a suboptimal concentration of AP resulted in an E dose-dependent inactivation of the lymphokine. Preformed E-alpha 2-M complexes, although ineffective by themselves at cleaving IFN-gamma, degraded the lymphokine, providing AP was also present in the reaction mixture. These data demonstrate that the destruction of small, biologically significant peptides by Pseudomonas proteases can involve protease-protease synergy that acts even in the presence of the serum protease inhibitor alpha 2-M.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470675      PMCID: PMC313337          DOI: 10.1128/iai.57.6.1668-1674.1989

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  A sandwich radioimmunoassay for human IFN-gamma.

Authors:  B Kelder; A Rashidbaigi; S Pestka
Journal:  Methods Enzymol       Date:  1986       Impact factor: 1.600

2.  Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.

Authors:  W Goldstein; G Döring
Journal:  Am Rev Respir Dis       Date:  1986-07

3.  Molecular alteration of alpha-2-macroglobulin by aliphatic amines.

Authors:  M Steinbuch; L Pejaudier; M Quentin; V Martin
Journal:  Biochim Biophys Acta       Date:  1968-01-22

4.  A new ultrasensitive method for the determination of proteolytic activity.

Authors:  H Rinderknecht; M C Geokas; P Silverman; B J Haverback
Journal:  Clin Chim Acta       Date:  1968-08       Impact factor: 3.786

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  The antigenicity of a pulmonary pathogen defined by monoclonal T cells.

Authors:  M J Parmely; R T Horvat; B H Iglewski; J Kanarek; D Furtado; R Van Enk
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

7.  Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases.

Authors:  T G Theander; A Kharazmi; B K Pedersen; L D Christensen; N Tvede; L K Poulsen; N Odum; M Svenson; K Bendtzen
Journal:  Infect Immun       Date:  1988-07       Impact factor: 3.441

8.  Pseudomonas aeruginosa alkaline protease degrades human gamma interferon and inhibits its bioactivity.

Authors:  R T Horvat; M J Parmely
Journal:  Infect Immun       Date:  1988-11       Impact factor: 3.441

9.  MACROGLOBULIN FROM HUMAN PLASMA WHICH FORMS AN ENZYMATICALLY ACTIVE COMPOUND WITH TRYPSIN.

Authors:  J W MEHL; W O'CONNELL; J DEGROOT
Journal:  Science       Date:  1964-08-21       Impact factor: 47.728

10.  Studies on the mechanism of T cell inhibition by the Pseudomonas aeruginosa phenazine pigment pyocyanine.

Authors:  J Nutman; M Berger; P A Chase; D G Dearborn; K M Miller; R L Waller; R U Sorensen
Journal:  J Immunol       Date:  1987-05-15       Impact factor: 5.422

View more
  12 in total

Review 1.  Proteases, cystic fibrosis and the epithelial sodium channel (ENaC).

Authors:  P H Thibodeau; M B Butterworth
Journal:  Cell Tissue Res       Date:  2012-05-22       Impact factor: 5.249

2.  Functional analysis of the Burkholderia cenocepacia ZmpA metalloprotease.

Authors:  C Kooi; C R Corbett; P A Sokol
Journal:  J Bacteriol       Date:  2005-07       Impact factor: 3.490

Review 3.  Inflammation in the lung in cystic fibrosis. A vicious cycle that does more harm than good?

Authors:  M Berger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

4.  Proinflammatory cytokine deficiency and pathogenesis of Pseudomonas aeruginosa keratitis in aged mice.

Authors:  J A Hobden; S A Masinick; R P Barrett; L D Hazlett
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

5.  Presence of quorum sensing system, virulence genes, biofilm formation and relationship among them and class 1 integron in carbapenem-resistant clinical Pseudomonas aeruginosa isolates.

Authors:  Ceren Başkan; Belgin Sırıken; Enis Fuat Tüfekci; Çetin Kılınç; Ömer Ertürk; İrfan Erol
Journal:  Arch Microbiol       Date:  2022-07-08       Impact factor: 2.667

6.  Activation of the epithelial sodium channel (ENaC) by the alkaline protease from Pseudomonas aeruginosa.

Authors:  Michael B Butterworth; Liang Zhang; Elisa M Heidrich; Michael M Myerburg; Patrick H Thibodeau
Journal:  J Biol Chem       Date:  2012-08-02       Impact factor: 5.157

7.  Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.

Authors:  Zhizhou Kuang; Yonghua Hao; Brent E Walling; Jayme L Jeffries; Dennis E Ohman; Gee W Lau
Journal:  PLoS One       Date:  2011-11-01       Impact factor: 3.240

Review 8.  Pseudomonas aeruginosa in Chronic Lung Infections: How to Adapt Within the Host?

Authors:  Emmanuel Faure; Kelly Kwong; Dao Nguyen
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561

9.  Cystic fibrosis-adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses.

Authors:  Shantelle L LaFayette; Daniel Houle; Trevor Beaudoin; Gabriella Wojewodka; Danuta Radzioch; Lucas R Hoffman; Jane L Burns; Ajai A Dandekar; Nicole E Smalley; Josephine R Chandler; James E Zlosnik; David P Speert; Joanie Bernier; Elias Matouk; Emmanuelle Brochiero; Simon Rousseau; Dao Nguyen
Journal:  Sci Adv       Date:  2015-07-31       Impact factor: 14.136

10.  Pseudomonas aeruginosa LasB Subverts Alveolar Macrophage Activity by Interfering With Bacterial Killing Through Downregulation of Innate Immune Defense, Reactive Oxygen Species Generation, and Complement Activation.

Authors:  Fabien Bastaert; Saadé Kheir; Vinciane Saint-Criq; Bérengère Villeret; Pham My-Chan Dang; Jamel El-Benna; Jean-Claude Sirard; Romé Voulhoux; Jean-Michel Sallenave
Journal:  Front Immunol       Date:  2018-07-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.